Bio/Pharma Business

Billions of Reasons to be Buoyant

September 02, 2023

Pharma's ability to continually reinvent itself will be critical in growing future business operations.

Bristol Myers Squibb Joins Cellares Program Focused on Automated Cell Therapy Manufacturing as Cellares is Launched as First IDMO

August 31, 2023

Bristol Myers Squibb has joined Cellares’ Technology Adoption Partnership program just as Cellares launches operations as an integrated development and manufacturing organization.

Unpacking Amgen v. Sanofi

August 31, 2023

Exploring the state of pharma patents following the Supreme Court’s Amgen v. Sanofi decision.

Sirio Europe Announces New Softgel Formulations

August 30, 2023

The new products aim to aid consumers with menopause and eye health-related issues.

Examining Microbubble Cell Separation Techniques with Brandon McNaughton

August 30, 2023

Brandon McNaughton, founder and CEO of Akadeum Life Sciences, discusses his start-up’s unique microbubble separation technology.

Three-Way Collaboration Between Rentschler Biopharma, CGT Catapult, and Refeyn Aims to Improve PAT for Gene Therapy Manufacturing

August 29, 2023

Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.

Danaher to Acquire Abcam in $5.7 Billion Deal

August 29, 2023

Danaher intends to acquire Abcam, a provider of life sciences assays and reagents, for $5.7 billion.

Royalty Pharma Places $500 Million Bet on Ferring Gene Therapy

August 24, 2023

Royalty Pharma agreed to spend up to $500 million for a 5.1 to 8% royalty on net sales of Ferring’s gene therapy adstiladrin (nadofaragene firadenovec-vcng).

Chiesi Global Rare Diseases and Aliada Therapeutics Partner to Advance Blood-Brain Barrier-Crossing Platform Technology for Drug Delivery

August 17, 2023

With this agreement, Chiesi Global Rare Diseases will co-develop drug delivery systems with Aliada Therapeutics for large-molecule therapeutics that can cross the blood-brain barrier.

Parexel and Partex Enter AI Alliance

August 16, 2023

The collaboration between Parexel and Partex is designed to leverage artificial intelligence-powered solutions to accelerate drug discovery and development.